-- Global Biomarkers Market is expected to reach USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
For Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market
The global biomarkers market is segmented on the basis of type, technology, application, indication, and geography.
Browse Full Report with Detailed TOC @ http://databridgemarketresearch.com/reports/global-biomarkers-market/
On the basis of types, global biomarkers market is segmented into consumables, services, and softwares.
On the basis of technology, global biomarkers market is segmented into efficacy, safety and validation biomakers.
Based on application, global biomarkers market is segmented into diagnostics, drug discovery, personalized medicine and disease risk assessment.
On the basis of indication, global biomarkers market is segmented into cancer, cardiovascular disorders, and immunological disorders.
Based on geography the market report covers data points for 28 countries across multiple geographies namely North America, South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
The Global Biomarkers Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major players operating in this market are
• QIAGEN
• PerkinElmer, Inc.
• Merck & Co.
• Bio-Rad Laboratories Inc.
• Enzo Biochem Inc.
• EKF Diagnostics Holdings Plc
• Abbott
• Siemens AG
• MESO SCALE DIAGOSTICS, LLC
• Agilent Technologies
• Singulex, Inc.
• Cisbio Bioassays
• Thermo Fisher Scientific Inc.
• Bruker
• Biosims Technologies
• Epigenomics AG
• Signosis, Inc.
• GE Healthcare
Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market
Table Of Content:
1.INTRODUCTION
1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET
1.2.MARKET SEGMENTATION & COVERAGE
1.2.1.CURRENCY AND PRICING
1.2.2.LIMITATION
1.2.3.STAKEHOLDERS
2.RESEARCH METHODOLOGY
2.1.KEY TAKEAWAYS
2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE
2.2.1.MARKET CRACKDOWN APPROACH
2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3.DATA TRIANGULATION
2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5.PRODUCT PIPELINE ANALYSIS
2.2.6.PORTER’S FIVE FORCES MATRIX
2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT
2.4.ASSUMPTIONS
3.MARKET LANDSCAPE SUMMARY
4.PREMIUM INSIGHTS
4.1.OVERVIEW
4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS
4.3.MARKET OVERVIEW
4.3.1.DRIVERS
4.3.1.1.INCREASING HEALTHCARE EXPENDITURE
4.3.1.2.NON-INVASIVE
4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS
4.3.1.4.GROWING NUMBER OF CROs
4.3.2.RESTRAINTS
4.3.3.OPPURTUNITIES
4.3.4.THREATS
4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5.EXECUTIVE SUMMARY
6.BIOMARKERS MARKET, BY PRODUCT TYPE
6.1.OVERVIEW
6.2.CONSUMABLES,
6.3.SERVICES,
6.4.SOFTWARE,
7.BIOMARKERS MARKET, BY TECHNOLOGY
7.1.OVERVIEW
7.2.SAFETY BIOMARKERS
7.3.EFFICACY BIOMARKERS
7.4.VALIDATION BIOMARKERS
8.BIOMARKERS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. DIAGNOSTICS DEVELOPMENT
8.3. DRUG DISCOVERY AND DEVELOPMENT
8.4. PERSONALIZED MEDICINE
8.5 DISEASE-RISK ASSESSMENT
8.6. OTHERS
9.BIOMARKERS MARKET, BY INDICATION
9.1.OVERVIEW
9.2.CANCER
9.3.CARDIOVASCULAR DISORDERS
9.4.NEUROLOGICAL DISORDERS
9.5.IMMUNOLOGICAL DISORDERS
9.6.OTHER DISEASES
10.BIOMARKERS MARKET, BY GEOGRAPHY
10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1.NORTH AMERICA
10.1.1.1.U.S.
10.1.1.2.CANADA
10.1.1.3.MEXICO
10.1.2.EUROPE
10.1.2.1.GERMANY
10.1.2.2.FRANCE
10.1.2.3.U.K.
10.1.2.4.ITALY
10.1.2.5.SPAIN
10.1.2.6.RUSSIA
10.1.2.7.TURKEY
10.1.2.8.BELGIUM
10.1.2.9.NETHERLANDS
10.1.2.10.SWITZERLAND
10.1.2.11.REST OF EUROPE
10.1.3.ASIA-PACIFIC (APAC)
10.1.3.1.JAPAN
10.1.3.2.CHINA
10.1.3.3.SOUTH KOREA
10.1.3.4.INDIA
10.1.3.5.AUSTRALIA
10.1.3.6.SINGAPORE
10.1.3.7.THAILAND
10.1.3.8.MALAYSIA
10.1.3.9.INDONESIA
10.1.3.10.PHILIPPINES
10.1.3.11.REST OF APAC
10.1.4.LATIN AMERICA
10.1.4.1.BRAZIL
10.1.4.2.REST OF LATIN AMERICA
10.1.5.MIDDLE EAST AND AFRICA
10.1.5.1.SOUTH AFRICA
10.1.5.2.REST OF MIDDLE EAST AND AFRICA
10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE
11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.7.MERGERS & ACQUISITIONS
11.8.NEW PRODUCT DEVELOPMENT & APPROVALS
11.9.EXPANSIONS
11.10.REGULATORY CHANGES
11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12.BIOMARKERS MARKET, COMPANY PROFILES
12.1.QIAGEN N.V
12.1.1.COMPANY OVERVIEW
12.1.2.SWOT ANALYSIS
12.1.3.REVENUE ANALYSIS
12.1.4.PRODUCT PORTFOLIO
12.1.5.RECENT DEVELOPEMENTS
12.1.6.DATA BRIDGE ANALYSIS
12.2.PERKINELMER, INC
12.2.1.COMPANY OVERVIEW
12.2.2.SWOT ANALYSIS
12.2.3.REVENUE ANALYSIS
12.2.4.PRODUCT PORTFOLIO
12.2.5.RECENT DEVELOPEMENTS
12.2.6.DATA BRIDGE ANALYSIS
12.3.MERCK & CO, INC.
12.3.1.COMPANY OVERVIEW
12.3.2.SWOT ANALYSIS
12.3.3.REVENUE ANALYSIS
12.3.4.PRODUCT PORTFOLIO
12.3.5.RECENT DEVELOPEMENTS
12.3.6.DATA BRIDGE ANALYSIS
12.4.BIO-RAD LABORATORIES
12.4.1.COMPANY OVERVIEW
12.4.2.SWOT ANALYSIS
12.4.3.REVENUE ANALYSIS
12.4.4.PRODUCT PORTFOLIO
12.4.5.RECENT DEVELOPEMENTS
12.4.6.DATA BRIDGE ANALYSIS
12.5.ENZO BIOCHEM, INC.,
12.5.1.COMPANY OVERVIEW
12.5.2.SWOT ANALYSIS
12.5.3.REVENUE ANALYSIS
12.5.4.PRODUCT PORTFOLIO
12.5.5.RECENT DEVELOPEMENTS
12.5.6.DATA BRIDGE ANALYSIS
12.6.EKF DIAGNOSTICS HOLDINGS, PLC
12.6.1.COMPANY OVERVIEW
12.6.2.SWOT ANALYSIS
12.6.3.REVENUE ANALYSIS
12.6.4.PRODUCT PORTFOLIO
12.6.5.RECENT DEVELOPEMENTS
12.6.6.DATA BRIDGE ANALYSIS
12.7.MESO SCALE DIAGNOSTICS
12.7.1.COMPANY OVERVIEW
12.7.2.SWOT ANALYSIS
12.7.3.REVENUE ANALYSIS
12.7.4.PRODUCT PORTFOLIO
12.7.5.RECENT DEVELOPEMENTS
12.7.6.DATA BRIDGE ANALYSIS
12.8.LLC, SINGULEX, INC.,
12.8.1.COMPANY OVERVIEW
12.8.2.SWOT ANALYSIS
12.8.3.REVENUE ANALYSIS
12.8.4.PRODUCT PORTFOLIO
12.8.5.RECENT DEVELOPEMENTS
12.8.6.DATA BRIDGE ANALYSIS
12.9.CISBIO BIOASSAYS
12.9.1.COMPANY OVERVIEW
12.9.2.SWOT ANALYSIS
12.9.3.REVENUE ANALYSIS
12.9.4.PRODUCT PORTFOLIO
12.9.5.RECENT DEVELOPEMENTS
12.9.6.DATA BRIDGE ANALYSIS
12.10.BIOSIMS TECHNOLOGIES
12.10.1.COMPANY OVERVIEW
12.10.2.SWOT ANALYSIS
12.10.3.REVENUE ANALYSIS
12.10.4.PRODUCT PORTFOLIO
12.10.5.RECENT DEVELOPEMENTS
12.10.6.DATA BRIDGE ANALYSIS
12.11. SIGNOSIS, INC.
12.11.1.COMPANY OVERVIEW
12.11.2.SWOT ANALYSIS
12.11.3.REVENUE ANALYSIS
12.11.4.PRODUCT PORTFOLIO
12.11.5.RECENT DEVELOPEMENTS
12.11.6.DATA BRIDGE ANALYSIS
13.APPENDIX
14.ABOUT DATA BRIDGE MARKET RESEARCH
Related Report
Global Leukemia Therapeutics Market – Industry Trends and Forecast to 2024
Global Leukemia Therapeutics Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, South America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA)) – Industry Trends and Forecast to 2024
Access Report: http://databridgemarketresearch.com/reports/global-leukemia-therapeutics-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Investor: [email protected]
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
Contact Info:
Name: Data Bridge Market Research
Email: Send Email
Organization: Data Bridge Market Research
Address: Amanora Chambers, Magarpatta Road, Hadapsar
Phone: +1-888-387-2818
Website: http://databridgemarketresearch.com/reports/global-biomarkers-market/
Release ID: 219704
Google
RSS